Brief: Mithra Pharmaceuticals, Searchlight Pharma Announce Donesta Licensing Agreement For Canada
31/07/2023 06:36
July 31 (Reuters) - Mithra Pharmaceuticals SA
MITRA.BR :
* MITHRA AND SEARCHLIGHT PHARMA ANNOUNCE DONESTA® LICENSING
AGREEMENT FOR CANADA
* PROMISING TOPLINE SAFETY RESULTS FROM DONESTA® PHASE 3
TRIAL IN
NORTH AMERICA
* MITHRA TO RECEIVE UP TO EUR 17.05 MILLION IN LICENSING
FEES AND
REGULATORY AND SALES MILESTONES
* SEARCHLIGHT PHARMA ANTICIPATES FILING OF CANADIAN
REGULATORY
SUBMISSION IN H1 2024
Source text for Eikon: [ID: nGNE3QNG2c]
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO